-
1 Comment
Sientra, Inc is currently in a long term uptrend where the price is trading 33.1% above its 200 day moving average.
From a valuation standpoint, the stock is 99.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.1.
Sientra, Inc's total revenue sank by 2.4% to $23M since the same quarter in the previous year.
Its net income has dropped by 4.9% to $-21M since the same quarter in the previous year.
Finally, its free cash flow grew by 42.9% to $-8M since the same quarter in the previous year.
Based on the above factors, Sientra, Inc gets an overall score of 3/5.
CurrencyCode | EUR |
---|---|
ISIN | US82621J1051 |
Sector | Healthcare |
Industry | Medical Devices |
Exchange | F |
Market Cap | 2M |
---|---|
Target Price | 11.29 |
Dividend Yield | 0.0% |
Beta | 1.59 |
PE Ratio | None |
Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names. The company also provides body contouring products; facial and nasal implants; saline filled sizers. It serves to hospitals, surgery centers, plastic surgeons, dermatologists and other specialties. The company was formerly known as Juliet Medical, Inc. and changed its name to Sientra, Inc. in April 2007. Sientra, Inc. was incorporated in 2003 and is headquartered in Santa Barbara, California.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for S0Z.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025